1. Home
  2. INTT vs HELP Comparison

INTT vs HELP Comparison

Compare INTT & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$18.37

Market Cap

234.0M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$5.34

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INTT
HELP
Founded
1981
N/A
Country
United States
Canada
Employees
407
50
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.0M
279.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
INTT
HELP
Price
$18.37
$5.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$13.50
$51.50
AVG Volume (30 Days)
294.8K
1.5M
Earning Date
05-05-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,801,000.00
N/A
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.06
N/A
52 Week Low
$5.64
$4.29
52 Week High
$20.00
$8.55

Technical Indicators

Market Signals
Indicator
INTT
HELP
Relative Strength Index (RSI) 64.14 51.78
Support Level $7.37 $4.55
Resistance Level N/A $6.26
Average True Range (ATR) 1.60 0.48
MACD 0.11 0.00
Stochastic Oscillator 73.15 44.02

Price Performance

Historical Comparison
INTT
HELP

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: